The internet is awash with claims about injectable peptides for fitness, but there’s almost no human research showing they ...

What started as a niche trend among bodybuilders and biohackers to lose fat and boost muscle growth is now making its way ...

The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly copay for eligible beneficiaries through Dec. 31, 2027. Medicare currently does not cover GLP-1 drugs for weight loss ...

Melanotan II, a viral tanning peptide known as the “Barbie drug,” promises faster, darker skin with less sun. But experts ...

European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.

Alembic Pharmaceuticals Ltd has received final USFDA approval for its methotrexate injection, used to treat various cancers and arthritis. The approval covers multi-dose and single-dose vials, ...

FDA final approval confirms therapeutic equivalence to Hospira’s methotrexate injection USP at identical strengths and vial presentations, enabling market entry via the abbreviated generic pathway.

Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Methotrexate Injection USP, the company ...

Prefilled aflibercept 2 mg syringes may deliver approximately 1.5 times the intended volume, raising post-injection IOP. Intravitreal injection (IVI) syringes prefilled with aflibercept 2 mg may ...

This is a syndicated post stub. Endocrinology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform ...

Feb 25 - Zydus Lifesciences (ZYDU.NS), opens new tab will launch generic versions of semaglutide injections for obesity and diabetes in India after patent expiry of the Ozempic active ingredient in ...

Lurid claims are being made around ski jumping ahead of the Milan Cortina Winter Olympics. Maddie Meyer / Getty Images The Winter Olympics has long been a battleground for marginal gains. Just look at ...